Skip to main content
JEIL PHARMACEUTICAL CO.,LTD logo

JEIL PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 271980 ISIN · KR7271980005 KO Manufacturing
Open in API
Filings indexed 135 across all filing types
Latest filing 2022-05-13 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 271980

About JEIL PHARMACEUTICAL CO.,LTD

https://www.jeilpharm.co.kr/english/

JEIL PHARMACEUTICAL CO.,LTD. is a company engaged in the development, manufacturing, and distribution of pharmaceutical products. Its portfolio includes both finished drug products and Active Pharmaceutical Ingredients (APIs). The company produces a diverse range of dosage forms, such as solid medicines (tablets and capsules), patches, and injections, with a strategic focus on becoming a leading manufacturer of injection-based medicines. Committed to developing high-value products, the company operates KGMP-certified manufacturing facilities. Research and development activities are central to its operations, driven by its dedicated R&D center.

Recent filings

Filing Released Lang Actions
분기보고서 (2022.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Jeil Pharmaceutical Co., Ltd. for the period of January 1, 2022, to March 31, 2022. It contains detailed financial statements, management discussion, and operational data, which fits the definition of an Interim/Quarterly Report (IR). Q1 2022
2022-05-13 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, dividend declarations, and director appointments. This matches the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it reports the official outcomes of shareholder votes at an AGM.
2022-03-23 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from Jeil Pharmaceutical. It provides a summary of the audit opinion (unqualified/proper) and key financial data (assets, liabilities, profit/loss) for the fiscal year. It is a short, standardized regulatory announcement (under 5,000 characters) that serves as a notification that the audit report has been submitted to the regulator, rather than the full, multi-page audit report document itself. Therefore, it falls under the Report Publication Announcement (RPA) category. FY 2021
2022-03-15 Korean
사업보고서 (2021.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Business Report' (사업보고서) for the fiscal year 2021 (Jan 1, 2021 to Dec 31, 2021) for Jeil Pharmaceutical Co., Ltd. It contains detailed sections on company overview, business operations, financial statements (consolidated and separate), management discussion and analysis, audit reports, and governance information. This structure corresponds to the standard annual filing required by the Financial Supervisory Service (FSS) and Korea Exchange (KRX), which is equivalent to a 10-K filing. FY 2021
2022-03-15 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Jeil Pharmaceutical Co., Ltd. It contains the agenda for the upcoming annual general meeting, including the approval of financial statements, election of directors, and dividend proposals. It also includes detailed financial statements (balance sheet, income statement, etc.) as part of the meeting materials. This type of document is classified as a Proxy Solicitation & Information Statement (PSI) because it provides shareholders with the necessary information to vote on matters at the meeting.
2022-03-08 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Jeil Pharmaceutical regarding a decision on cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the date of the board resolution. This fits the definition of a 'Notice of Dividend Amount' (DIV) as it provides specific details regarding dividend payments to shareholders.
2022-03-04 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.